Copyright Reports & Markets. All rights reserved.

Global Weight Loss Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Weight Loss Therapeutics Market Overview

    • 1.1 Product Overview and Scope of Weight Loss Therapeutics
    • 1.2 Classification of Weight Loss Therapeutics by Types
      • 1.2.1 Global Weight Loss Therapeutics Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Weight Loss Therapeutics Revenue Market Share by Types in 2018
      • 1.2.3 Appetite Suppression
      • 1.2.4 Increasing Body Metabolism
      • 1.2.5 Interfering with the Digestion Absorption Patterns
    • 1.3 Global Weight Loss Therapeutics Market by Application
      • 1.3.1 Global Weight Loss Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospitals
      • 1.3.3 Specialized Clinics
      • 1.3.4 Retail Pharmacies
      • 1.3.5 Mail Order Pharmacies
      • 1.3.6 Others
    • 1.4 Global Weight Loss Therapeutics Market by Regions
      • 1.4.1 Global Weight Loss Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Weight Loss Therapeutics Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Weight Loss Therapeutics Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Weight Loss Therapeutics Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Weight Loss Therapeutics Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Weight Loss Therapeutics Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Weight Loss Therapeutics (2014-2024)

    2 Company Profiles

    • 2.1 Abbott
      • 2.1.1 Business Overview
      • 2.1.2 Weight Loss Therapeutics Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Abbott Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Novartis AG
      • 2.2.1 Business Overview
      • 2.2.2 Weight Loss Therapeutics Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Novartis AG Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Arena Pharmaceuticals
      • 2.3.1 Business Overview
      • 2.3.2 Weight Loss Therapeutics Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Arena Pharmaceuticals Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sanofi
      • 2.4.1 Business Overview
      • 2.4.2 Weight Loss Therapeutics Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sanofi Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pfizer
      • 2.5.1 Business Overview
      • 2.5.2 Weight Loss Therapeutics Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pfizer Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Novo Nordisk
      • 2.6.1 Business Overview
      • 2.6.2 Weight Loss Therapeutics Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Novo Nordisk Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 VIVUS
      • 2.7.1 Business Overview
      • 2.7.2 Weight Loss Therapeutics Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 VIVUS Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Johnson & Johnson
      • 2.8.1 Business Overview
      • 2.8.2 Weight Loss Therapeutics Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Johnson & Johnson Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Orexigen Therapeutics
      • 2.9.1 Business Overview
      • 2.9.2 Weight Loss Therapeutics Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Orexigen Therapeutics Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Biocon
      • 2.10.1 Business Overview
      • 2.10.2 Weight Loss Therapeutics Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Biocon Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Eisai
      • 2.11.1 Business Overview
      • 2.11.2 Weight Loss Therapeutics Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Eisai Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Eli Lilly
      • 2.12.1 Business Overview
      • 2.12.2 Weight Loss Therapeutics Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Eli Lilly Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Roche
      • 2.13.1 Business Overview
      • 2.13.2 Weight Loss Therapeutics Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Roche Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Amgen
      • 2.14.1 Business Overview
      • 2.14.2 Weight Loss Therapeutics Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Amgen Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Zafgen
      • 2.15.1 Business Overview
      • 2.15.2 Weight Loss Therapeutics Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Zafgen Weight Loss Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Weight Loss Therapeutics Market Competition, by Players

    • 3.1 Global Weight Loss Therapeutics Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Weight Loss Therapeutics Players Market Share
      • 3.2.2 Top 10 Weight Loss Therapeutics Players Market Share
    • 3.3 Market Competition Trend

    4 Global Weight Loss Therapeutics Market Size by Regions

    • 4.1 Global Weight Loss Therapeutics Revenue and Market Share by Regions
    • 4.2 North America Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.5 South America Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

    5 North America Weight Loss Therapeutics Revenue by Countries

    • 5.1 North America Weight Loss Therapeutics Revenue by Countries (2014-2019)
    • 5.2 USA Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

    6 Europe Weight Loss Therapeutics Revenue by Countries

    • 6.1 Europe Weight Loss Therapeutics Revenue by Countries (2014-2019)
    • 6.2 Germany Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.3 UK Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.4 France Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Weight Loss Therapeutics Revenue by Countries

    • 7.1 Asia-Pacific Weight Loss Therapeutics Revenue by Countries (2014-2019)
    • 7.2 China Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.5 India Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

    8 South America Weight Loss Therapeutics Revenue by Countries

    • 8.1 South America Weight Loss Therapeutics Revenue by Countries (2014-2019)
    • 8.2 Brazil Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Weight Loss Therapeutics by Countries

    • 9.1 Middle East and Africa Weight Loss Therapeutics Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Weight Loss Therapeutics Revenue and Growth Rate (2014-2019)

    10 Global Weight Loss Therapeutics Market Segment by Type

    • 10.1 Global Weight Loss Therapeutics Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Weight Loss Therapeutics Market Forecast by Type (2019-2024)
    • 10.3 Appetite Suppression Revenue Growth Rate (2014-2024)
    • 10.4 Increasing Body Metabolism Revenue Growth Rate (2014-2024)
    • 10.5 Interfering with the Digestion Absorption Patterns Revenue Growth Rate (2014-2024)

    11 Global Weight Loss Therapeutics Market Segment by Application

    • 11.1 Global Weight Loss Therapeutics Revenue Market Share by Application (2014-2019)
    • 11.2 Weight Loss Therapeutics Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2014-2019)
    • 11.4 Specialized Clinics Revenue Growth (2014-2019)
    • 11.5 Retail Pharmacies Revenue Growth (2014-2019)
    • 11.6 Mail Order Pharmacies Revenue Growth (2014-2019)
    • 11.7 Others Revenue Growth (2014-2019)

    12 Global Weight Loss Therapeutics Market Size Forecast (2019-2024)

    • 12.1 Global Weight Loss Therapeutics Market Size Forecast (2019-2024)
    • 12.2 Global Weight Loss Therapeutics Market Forecast by Regions (2019-2024)
    • 12.3 North America Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
    • 12.4 Europe Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
    • 12.6 South America Weight Loss Therapeutics Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Weight Loss Therapeutics Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Description

      Scope of the Report:
      The global Weight Loss Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Weight Loss Therapeutics.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Weight Loss Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Weight Loss Therapeutics market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Abbott
      Novartis AG
      Arena Pharmaceuticals
      Sanofi
      Pfizer
      Novo Nordisk
      VIVUS
      Johnson & Johnson
      Orexigen Therapeutics
      Biocon
      Eisai
      Eli Lilly
      Roche
      Amgen
      Zafgen

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Appetite Suppression
      Increasing Body Metabolism
      Interfering with the Digestion Absorption Patterns

      Market Segment by Applications, can be divided into
      Hospitals
      Specialized Clinics
      Retail Pharmacies
      Mail Order Pharmacies
      Others
      Buy now